Corbus Presents Latest Preclinical Data for CRB-601 at the New York Academy of Sciences Frontiers in Cancer Immunotherapy Conference May 11, 2022
Corbus Pharmaceuticals Reports First Quarter 2022 Financial Results and Provides Corporate Update May 10, 2022
Corbus Presents First Preclinical Data for CRB-601 at the American Association for Cancer Research (AACR) Annual Meeting April 8, 2022
Corbus Pharmaceuticals to Present at the Oppenheimer 32nd Annual Healthcare Conference March 11, 2022
Corbus Pharmaceuticals Reports Fourth Quarter and Year-End 2021 Financial Results and Provides Corporate Updates March 8, 2022